Adverse event (flu‐like symptoms) · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (flu‐like symptoms) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Adverse effect: fatigue · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (fatigue) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Neurotoxicity · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (neurotoxicity) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Overall survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in overall survival compared with observation alone (low certainty).
1 finding from 1 review
Progression‐free survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in progression‐free survival compared with observation alone (low certainty).
1 finding from 1 review
Adverse event (flu‐like symptoms) · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon may leads to higher adverse event (flu‐like symptoms) compared with observation alone (low certainty).
1 finding from 1 review
Adverse effect: fatigue · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon may leads to higher adverse event (fatigue) compared with observation alone (low certainty).
1 finding from 1 review
All‐cause mortality · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All cardiovascular death · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in death from cardiovascular causes compared with placebo or no treatment (low certainty).
1 finding from 1 review
Non‐fatal MI · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in myocardial infarction (non‐fatal) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Stroke/TIA (non‐fatal) · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in stroke/TIA (non‐fatal) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Participant‐reported outcomes－not measured · participants with improving outcomes during and after noncardiac vascular surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse muscle effects · participants with improving outcomes during and after noncardiac vascular surgery.
1 finding from 1 review
Intervention not reported
Surgical failure (intraocular pressure >21mmHg) ( · patients with glaucoma surgery
The intervention probably leads to lower surgical failure (intraocular pressure >21mmHg) ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Intraocular pressure ( · patients with glaucoma surgery
1 finding from 1 review
Intervention not reported
Adverse effect: cataract · patients with glaucoma surgery
The intervention showed no clear difference in adverse effect: cataract (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes overall five year survival ‐ Colorectal cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Permanent stoma rate ‐ Rectal cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes permanent stoma rate ‐ Rectal cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Abdominoperineal excision of the rectum rate ‐ Rectal cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes abdominoperineal excision of the rectum rate ‐ Rectal cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Overall five year survival ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower overall five year survival ‐ Colorectal cancer (low certainty).
1 finding from 1 review